30-day mortality after SACT (systemic anti-cancer therapy) for lung cancer at the Northern Trust SACT clinic (2019-2021)

被引：0
|
作者：
Lau, Yan Hei [1 ,2 ]
Mezynski, Janusz [1 ,2 ]
McAleese, Jonathan [1 ,2 ]
机构：
[1] Antrim Area Hosp, Antrim, North Ireland
[2] Northern Ireland Canc Ctr, Belfast, North Ireland
来源：
LUNG CANCER | 2023年 / 178卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
111
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 46 条
  • [21] Is 30-day mortality after systemic anticancer therapy in lung cancer in the era of varied treatments still relevant?
    Parikh, S. P.
    Jain, P.
    Clarke, K.
    Franks, K.
    Teo, M.
    Dickinson, P.
    Young, A.
    Murray, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S878 - S878
  • [22] Stereotactic ablative radiotherapy (SABR) for lung oligometastases can prevent or delay need for systemic anti-cancer treatment (SACT): single institution experience
    Lynch, Sophie
    Ahmad, Shahreen
    Taylor, Benjamin
    Skwarski, Michael
    Smith, Daniel
    LUNG CANCER, 2023, 178 : S56 - S57
  • [23] What are the competency requirements for clinical pharmacist verification of systemic anti-cancer therapy (SACT) prescribed within a clinical trial? A consensus study
    Gilluley, Nikki
    Bennie, Marion
    Elliott, Ben
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (07) : 1524 - 1533
  • [24] Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality
    Pezzi, Christopher M.
    Mallin, Katherine
    Mendez, Andres Samayoa
    Gay, Emmelle Greer
    Putnam, Joe B., Jr.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (05): : 2269 - 2277
  • [25] Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality Discussion
    Wright, Cameron D.
    Pezzi, Dr
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (05): : 2277 - U654
  • [26] Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude
    Strand, Trond-Eirik
    Rostad, Hans
    Damhuis, Ronald A. M.
    Norstein, Jarle
    THORAX, 2007, 62 (11) : 991 - 997
  • [27] Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-Cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in England
    Gannon, Melissa Ruth
    Park, Min Hae
    Miller, Katie
    Dodwell, David
    Horgan, Kieran
    Clements, Karen
    Medina, Jibby
    Cromwell, David Alan
    CANCER EPIDEMIOLOGY, 2023, 83
  • [28] 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study
    Wallington, Michael
    Saxon, Emma B.
    Bomb, Martine
    Smittenaar, Rebecca
    Wickenden, Matthew
    McPhail, Sean
    Rashbass, Jem
    Chao, David
    Dewar, John
    Talbot, Denis
    Peake, Michael
    Perren, Timothy
    Wilson, Charles
    Dodwell, David
    LANCET ONCOLOGY, 2016, 17 (09): : 1203 - 1216
  • [29] Patterns of chemotherapy use and outcomes in advanced non-small cell lung cancer by age in England: A retrospective analysis of the population-based Systemic Anti-Cancer Treatment (SACT) dataset
    Pilleron, Sophie
    Morris, Eva J. A.
    Dodwell, David
    Franks, Kevin N.
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (07)
  • [30] Preoperative Assessment of Risk Factors as a Predictor of 30-Day Mortality and Morbidity after Lung Resection for Lung Cancer
    Han, Jong In
    Lee, Guie Young
    EWHA MEDICAL JOURNAL, 2007, 30 (01): : 37 - 46
12345